Literature DB >> 33050827

A local-neighborhood Lassen plot filter for creating occupancy and non-displaceable binding images.

Bart de Laat1, Evan D Morris1,2,3,4.   

Abstract

For radioligands without a reference region, the Lassen plot can be used to estimate receptor occupancy by an exogenous drug (ODrug). However, the Lassen plot is not well-suited for spatial variation in ODrug. To overcome this limitation, we introduce a Lassen plot filter, i.e. a Lassen plot applied to local neighborhoods in PET images. Image data were simulated with regional variation in VND, ODrug, both, or neither and analyzed using the change in binding potential (ΔBPND), the conventional Lassen plot, and the Lassen plot filter at the region of interest (ROI) and voxel level. All methods were also applied to a human [11C]flumazenil occupancy study using PF-06372865. This combination of a non-selective radioligand and selective drug should lead to varying ODrug provided the distribution of subtypes varies spatially. In contrast with ΔBPND and the conventional Lassen plot, ROI-level and voxel-level Lassen plot filter estimates remained unbiased in the presence of regional variation in VND or ODrug. In the [11C]flumazenil data-set, ODrug was shown to vary regionally in accordance with the distribution of binding sites for [11C]flumazenil and PF-06372865. We demonstrate that a local-neighborhood Lassen plot filter provides robust and unbiased estimates of ODrug and VND without the need for any user intervention.

Entities:  

Keywords:  Lassen plot; Lassen plot filter; non-displaceable binding; occupancy; positron emission tomography

Mesh:

Substances:

Year:  2020        PMID: 33050827      PMCID: PMC8142134          DOI: 10.1177/0271678X20950486

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  16 in total

1.  Measuring drug occupancy in the absence of a reference region: the Lassen plot re-visited.

Authors:  Vincent J Cunningham; Eugenii A Rabiner; Mark Slifstein; Marc Laruelle; Roger N Gunn
Journal:  J Cereb Blood Flow Metab       Date:  2009-09-09       Impact factor: 6.200

2.  Differential occupancy of somatodendritic and postsynaptic 5HT(1A) receptors by pindolol: a dose-occupancy study with [11C]WAY 100635 and positron emission tomography in humans.

Authors:  D Martinez; D Hwang; O Mawlawi; M Slifstein; J Kent; N Simpson; R V Parsey; T Hashimoto; Y Huang; A Shinn; R Van Heertum; A Abi-Dargham; S Caltabiano; A Malizia; H Cowley; J J Mann; M Laruelle
Journal:  Neuropsychopharmacology       Date:  2001-03       Impact factor: 7.853

3.  Pharmacology in translation: the preclinical and early clinical profile of the novel α2/3 functionally selective GABAA receptor positive allosteric modulator PF-06372865.

Authors:  Sarah A Nickolls; Rachel Gurrell; Guido van Amerongen; Juha Kammonen; Lishuang Cao; Adam R Brown; Clara Stead; Andy Mead; Christine Watson; Cathleen Hsu; Robert M Owen; Andy Pike; Rebecca L Fish; Laigao Chen; Ruolun Qiu; Evan D Morris; Gang Feng; Mark Whitlock; Donal Gorman; Joop van Gerven; David S Reynolds; Pinky Dua; Richard P Butt
Journal:  Br J Pharmacol       Date:  2018-01-18       Impact factor: 8.739

Review 4.  Structure and pharmacology of gamma-aminobutyric acidA receptor subtypes.

Authors:  W Sieghart
Journal:  Pharmacol Rev       Date:  1995-06       Impact factor: 25.468

5.  Benzodiazepine receptor quantification in vivo in humans using [11C]flumazenil and PET: application of the steady-state principle.

Authors:  N A Lassen; P A Bartenstein; A A Lammertsma; M C Prevett; D R Turton; S K Luthra; S Osman; P M Bloomfield; T Jones; P N Patsalos
Journal:  J Cereb Blood Flow Metab       Date:  1995-01       Impact factor: 6.200

6.  Impact of D2 receptor internalization on binding affinity of neuroimaging radiotracers.

Authors:  Ningning Guo; Wen Guo; Michaela Kralikova; Man Jiang; Ira Schieren; Raj Narendran; Mark Slifstein; Anissa Abi-Dargham; Marc Laruelle; Jonathan A Javitch; Stephen Rayport
Journal:  Neuropsychopharmacology       Date:  2009-12-02       Impact factor: 7.853

7.  Imaging the GABA-benzodiazepine receptor subtype containing the alpha5-subunit in vivo with [11C]Ro15 4513 positron emission tomography.

Authors:  Anne Lingford-Hughes; Susan P Hume; Adrian Feeney; Ella Hirani; Safiye Osman; Vincent J Cunningham; Victor W Pike; David J Brooks; David J Nutt
Journal:  J Cereb Blood Flow Metab       Date:  2002-07       Impact factor: 6.200

8.  Comparison of plasma input and reference tissue models for analysing [(11)C]flumazenil studies.

Authors:  Ursula M H Klumpers; Dick J Veltman; Ronald Boellaard; Emile F Comans; Cassandra Zuketto; Maqsood Yaqub; Jurgen E M Mourik; Mark Lubberink; Witte J G Hoogendijk; Adriaan A Lammertsma
Journal:  J Cereb Blood Flow Metab       Date:  2007-10-10       Impact factor: 6.200

9.  D2 dopamine receptor internalization prolongs the decrease of radioligand binding after amphetamine: a PET study in a receptor internalization-deficient mouse model.

Authors:  Mette Skinbjerg; Jeih-San Liow; Nicholas Seneca; Jinsoo Hong; Shuiyu Lu; Annika Thorsell; Markus Heilig; Victor W Pike; Christer Halldin; David R Sibley; Robert B Innis
Journal:  Neuroimage       Date:  2010-01-22       Impact factor: 6.556

10.  PET measurement of cyclooxygenase-2 using a novel radioligand: upregulation in primate neuroinflammation and first-in-human study.

Authors:  Stal Shrestha; Min-Jeong Kim; Mark Eldridge; Michael L Lehmann; Michael Frankland; Jeih-San Liow; Zu-Xi Yu; Michelle Cortes-Salva; Sanjay Telu; Ioline D Henter; Evan Gallagher; Jae-Hoon Lee; J Megan Fredericks; Chelsie Poffenberger; George Tye; Yanira Ruiz-Perdomo; Fernanda Juarez Anaya; Jose A Montero Santamaria; Robert L Gladding; Sami S Zoghbi; Masahiro Fujita; James D Katz; Victor W Pike; Robert B Innis
Journal:  J Neuroinflammation       Date:  2020-05-02       Impact factor: 8.322

View more
  1 in total

1.  NRM 2021 Abstract Booklet.

Authors: 
Journal:  J Cereb Blood Flow Metab       Date:  2021-12       Impact factor: 6.960

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.